Log in
Enquire now
NewLink Genetics

NewLink Genetics

NewLink Genetics is a biopharmaceutical company focused on the discovery and development of immuno-oncology products.

OverviewStructured DataIssuesContributors

NewLink Genetics is a biopharmaceutical company developing cancer immunotherapies that is headquartered in Ames, Iowa and was founded in 1999 by Charles Link and Nicholas Vahanian.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

NewLink Genetics Corporation

https://www.globenewswire.com/news-release/2018/11/15/1652369/0/en/NewLink-Genetics-Announces-Merck-Has-Begun-Rolling-Submission-of-Licensure-Application-for-Ebola-vaccine-V920-rVSV-G-ZEBOV-GP-to-U-S-Food-and-Drug-Administration.html

Web

UPDATED: NewLink wins $26.1M in government funding to advance Ebola vaccine

Amirah Al Idrus

https://www.fiercepharma.com/infectious-diseases/updated-newlink-wins-26-1m-government-funding-to-advance-ebola-vaccine

Web

References

Find more companies like NewLink Genetics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.